NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) › Shareholders' EquityNEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2009: -$1.2K2010: -$4.3K2011: -$3.3K2012: -$17.2K2013: -$30.3K2014: -$35.4K2015: -$81.5K2016: -$266.2K2017: -$5.04M2018: -$4.40M2019: -$1.24M2020: $2.07M2021: $6.55M2022: $9.60M2023: $6.25M2024: $822.0K2025: $7.07M$7.07M2009Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$7.07M+760.4%2024$822.0K-86.8%2023$6.25M-34.9%2022$9.60M+46.5%2021$6.55M+217.2%2020$2.07M+267.0%2019-$1.24M+71.8%2018-$4.40M+12.7%2017-$5.04M-1791.9%2016-$266.2K-226.7%2015-$81.5K-130.3%2014-$35.4K-16.8%2013-$30.3K-75.7%2012-$17.2K-426.0%2011-$3.3K+24.2%2010-$4.3K-254.1%2009-$1.2K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share